财中社12月3日电方舟健客(06086)发布自愿性公告,宣布公司股份已获选纳入恒生香港上市生物科技指数,自2024年12月9日起生效。该指数旨在反映香港上市生物科技公司的整体表现,董事会认为这一纳入将提升公司的形象,并为客户、合作伙伴及投资者创造参与公司创新互联网保健解决方案的机会。
此次公告意在告知股东及潜在投资者有关近期业务更新,董事会对这一进展表示欣喜,认为将有助于吸引更广泛的投资者关注。
(文章来源:财中社)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.